Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway
Department of Medicine, Nordlands Hospital, Bodo, Norway.
Open Heart. 2021 Aug;8(2). doi: 10.1136/openhrt-2021-001777.
To compare the population proportion at high risk of cardiovascular disease (CVD) using the Norwegian NORRISK 1 that predicts 10-year risk of CVD mortality and the Norwegian national guidelines from 2009, with the updated NORRISK 2 that predicts 10-year risk of both fatal and non-fatal risk of CVD and the Norwegian national guidelines from 2017.
We included participants from the Norwegian population-based Tromsø Study (2015-2016) aged 40-69 years without a history of CVD (n=16 566). The total proportion eligible for intervention was identified by NORRISK 1 and the 2009 guidelines (serum total cholesterol ≥8 mmol/L, systolic blood pressure ≥160 mm Hg or diastolic blood pressure ≥100 mm Hg) and NORRISK 2 and the 2017 guidelines (serum total cholesterol ≥7 mmol/L, low density lipoprotein (LDL) cholesterol ≥5 mmol/L, systolic blood pressure ≥160 mm Hg or diastolic blood pressure ≥100 mm Hg).
The total proportion at high risk as defined by a risk score was 12.0% using NORRISK 1 and 9.8% using NORRISK 2. When including single risk factors specified by the guidelines, the total proportion eligible for intervention was 15.5% using NORRISK 1 and the 2009 guidelines and 18.9% using NORRISK 2 and the 2017 guidelines. The lowered threshold for total cholesterol and specified cut-off for LDL cholesterol stand for a large proportion of the increase in population at risk.
The population proportion eligible for intervention increased by 3.4 percentage points from 2009 to 2017 using the revised NORRISK 2 score and guidelines.
比较使用挪威 NORRISK 1(预测 CVD 死亡风险 10 年的心血管疾病风险)和 2009 年挪威国家指南、以及预测 CVD 致命和非致命风险 10 年的更新版 NORRISK 2 和 2017 年挪威国家指南的人群中 CVD 高危人群的比例。
我们纳入了无 CVD 病史的挪威人群基础 Tromsø 研究(2015-2016 年)中年龄在 40-69 岁的参与者(n=16566)。使用 NORRISK 1 和 2009 年指南(血清总胆固醇≥8mmol/L、收缩压≥160mmHg 或舒张压≥100mmHg)以及 NORRISK 2 和 2017 年指南(血清总胆固醇≥7mmol/L、低密度脂蛋白胆固醇≥5mmol/L、收缩压≥160mmHg 或舒张压≥100mmHg)来确定符合干预条件的总比例。
使用 NORRISK 1 定义的风险评分,高危人群的总比例为 12.0%,使用 NORRISK 2 为 9.8%。当纳入指南规定的单一危险因素时,使用 NORRISK 1 和 2009 年指南,符合干预条件的总比例为 15.5%,使用 NORRISK 2 和 2017 年指南为 18.9%。总胆固醇的阈值降低和 LDL 胆固醇的特定截止值代表高危人群比例的大幅增加。
使用修订后的 NORRISK 2 评分和指南,2009 年至 2017 年符合干预条件的人群比例增加了 3.4 个百分点。